BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11942974)

  • 1. Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer.
    Petrovich Z; Lieskovsky G; Stein JP; Huberman M; Skinner DG
    BJU Int; 2002 Apr; 89(6):604-11. PubMed ID: 11942974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonrandomized comparison of surgery with and without adjuvant pelvic irradiation for patients with pT3N0 adenocarcinoma of the prostate.
    Petrovich Z; Lieskovsky G; Langholz B; Huberman M; Streeter O; Skinner DG
    Am J Clin Oncol; 2001 Dec; 24(6):537-46. PubMed ID: 11801750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer.
    Petrovich Z; Lieskovsky G; Langholz B; Jozsef G; Streeter OE; Skinner DG
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):600-9. PubMed ID: 12062603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?
    Choo R; Hruby G; Hong J; Hong E; DeBoer G; Danjoux C; Morton G; Klotz L; Bhak E; Flavin A
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):674-80. PubMed ID: 11849789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate.
    Petrovich Z; Lieskovsky G; Langholz B; Formenti S; Baert L; Streeter O; Skinner DG
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):139-47. PubMed ID: 9422570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
    Kamat AM; Babaian K; Cheung MR; Naya Y; Huang SH; Kuban D; Babaian RJ
    J Urol; 2003 Nov; 170(5):1860-3. PubMed ID: 14532793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage radiotherapy for biochemical recurrence after radical prostatectomy: a study of 62 patients.
    Peyromaure M; Allouch M; Eschwege F; Verpillat P; Debré B; Zerbib M
    Urology; 2003 Sep; 62(3):503-7. PubMed ID: 12946755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer.
    Vicini FA; Ziaja EL; Kestin LL; Brabbins DS; Stromberg JS; Gonzalez JA; Martinez AA
    Urology; 1999 Jul; 54(1):111-7. PubMed ID: 10414736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years.
    Anscher MS; Clough R; Dodge R
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):369-75. PubMed ID: 10974449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate.
    Catton C; Gospodarowicz M; Warde P; Panzarella T; Catton P; McLean M; Milosevic M
    Radiother Oncol; 2001 Apr; 59(1):51-60. PubMed ID: 11295206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy.
    Kupelian PA; Elshaikh M; Reddy CA; Zippe C; Klein EA
    J Clin Oncol; 2002 Aug; 20(16):3376-85. PubMed ID: 12177097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant radiotherapy in patients with pathologic Stage C (pT3N0) adenocarcinoma of the prostate.
    Petrovich Z; Lieskovsky G; Langholz B; Bochner B; Formenti S; Streeter O; Skinner DG
    Urology; 1999 Jun; 53(6):1184-93. PubMed ID: 10367850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis.
    Valicenti RK; Gomella LG; Ismail M; Strup SE; Mulholland SG; Dicker AP; Petersen RO; Newschaffer CJ
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):53-8. PubMed ID: 10477006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.
    Ray ME; Thames HD; Levy LB; Horwitz EM; Kupelian PA; Martinez AA; Michalski JM; Pisansky TM; Shipley WU; Zelefsky MJ; Zietman AL; Kuban DA
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1140-50. PubMed ID: 16198506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?
    Hsu CC; Paciorek AT; Cooperberg MR; Roach M; Hsu IC; Carroll PR
    BJU Int; 2015 Nov; 116(5):713-20. PubMed ID: 25600860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [pT3N0 prostate cancer treated with radical prostatectomy as sole treatment: Oncological results and predictive factors of recurrence].
    Barry Delongchamps N; Peyromaure M; Kpatcha F; Beuvon F; Legrand G; Zerbib M
    Prog Urol; 2012 Feb; 22(2):100-5. PubMed ID: 22284594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.